研究業績(論文)

2019年(26)


1.Shuto K, Mori M, Kosugi C, Narushima K, Nakabayashi S, Fujisiro T, Sato A, Hayano K, Shimizu H, Koda K:Hepatic blood flow by perfusion computed tomography as an imaging biomarker for patients with gastric cancer Oncology Letters 17: 3267-3276 2019

2.Hanaoka T, Kouno T, Shuto K, Ohira G, Hayano K, Gunji H, Touma T, Aoyagi T, Narushima K, Imanishi S, Tochigi T, Fujishiro T, Matsubara H:Diagnostic and clinical usefulness of thin –slice CT/DWI in the diagnosis of esophageal cancer lymph node metastasis Chiba Medical J 95E: 33-40,2019

3.Sugimoto K, Yamada T, Ishiyama S, Nakamura M, Yoshida Y, Hasegawa S, Yokomizo H, Naritaka Y, Sakuyama N, Ochiai T, Sonoda H, Tani M, Enomoto M, Katsumata K, Yamaguchi T, Ohta R, Isihimaru K, Watanabe y, Koda K, Sakamaoto K:Study protocol of regorafenib escalation for colorectal cancer (RECC): A phase U multicenter clinical trial of the efficacy and safety of regorafenib dose escalation therapy as the third or fourth line therapy for unrespectable/ Recurrent colorectal cancer Juntendo Medical Journal 65: 2019

4.Yoshida Y, Yamada T, Matsuoka H, Sonoda H, Fukazawa A, Yoshida H, Ishida H, Hirata K, Hasegawa S, Sakamoto K, Otsuka T, Koda K.A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study).  J Anus Rectum Colon. 2019 Jul 30;3(3):136-141. 

5.Kumamoto K, Nakachi Y, Mizuno Y, Yokoyama M, Ishibashi K, Kosugi C, Koda K, Kobayashi M, Tanakaya K, Matsunami T, Eguchi H, Okazaki Y, Ishida H.Expressions of 10 genes as candidate predictors of recurrence in stage III colon cancer patients receiving adjuvant oxaliplatin-based chemotherapy. Oncol Lett. 2019 Aug;18(2):1388-1394. 

6.Mori M, Shuto K, Hirano A, Kosugi C, Narushima K, Koda K.Laparoscopic surgery for an esophageal duplication cyst using a near-infrared indocyanine green fluorescence system: A case report. Asian J Endosc Surg. 2019 Jul 1. doi: 10.1111/ases.12729. [Epub ahead of print]

7.Yoshimatsu K, Ishibashi K, Koda K, Yokomizo H, Oda N, Oshiro M, Kato H, Oya M, Nakajima H, Ooki S, Maekawa H, Matsunami T, Tsubaki M, Yamada T, Kobayashi M, Tanakaya K, Yokoyama M, Ishida H. A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy. Surg Today. 2019; 49(6): 498-506. 

8.Keiji Koda, Masato Yamazaki, Kiyohiko Shuto, Chihiro Kosugi, Mikito Mori, Kazuo Narushima, Isamu Hosokawa, Hiroaki Shimizu  Etiology and management of low anterior resection syndrome based on the normal defecation mechanism.  Surgery Today 2019;49(10):803-808.

9.Keiji Koda  Chemoradiation for Rectal Cancer.  In Ishida H, Koda K (eds.) Recent Advances in the Treatment of Colorectal Cancer.  Springer Nature Singapore 2019, pp 71-77.

10.Hosokawa I, Shimizu H, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S, Koda K, Miyazaki M, Ohtsuka M.Outcomes of left trisectionectomy and right hepatectomy for perihilar cholangiocarcinoma.HPB (Oxford). 2019 ;21:489-498.

11. Hosokawa I, Ohtsuka M, Yoshitomi H, Furukawa K, Miyazaki M, Shimizu H.Right intersectional transection plane based on portal inflow in left trisectionectomy.Surg Radiol Anat. 2019;41:589-593. d

12.Ashizawa Y, Kuboki S, Nojima H , Yoshitomi H, Furukawa K, Takayashiki T, Takano S, Miyazaki M, Ohtsuka M OLFM4 Enhances STAT3 Activation and Promotes Tumor  Progression by Inhibiting GRIM19 Expression in Human Hepatocellular Carcinoma Hepatology Communications 2019; 3: 954-970

13.Yokota T, Takano S, Yoshitomi H, Kagawa S, Furukawa K, Takayashiki T, Kuboki S, Suzuki D, Sakai N, Nojima H, Mishima T, Nakadai E, Ohtsuka M. Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab-paclitaxel chemotherapy: A case report. Mol Clin Oncol 2019 ; 10: 419-424

14.Nakada S, Kuboki S, Nojima H, Yoshitomi H, Furukawa K, Takayashiki T, Takano S, Miyazaki M, Ohtsuka M. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer. Ann Surg Oncol. 2019; 26: 907-917

15.Murakami T, Wada T, Ishibe A, Akiyama H, Endo I.Abdominal drainage may be a risk factor for surgical site infection following appendectomy.Asian J Surg. 2019 42:897-898.

16.Murakami T, Hiroshima Y, Miyake K, Kiyuna T, Endo I, Zhao M, Hoffman RM.Efficacy of Tumor-Targeting Salmonella typhimurium A1-R against Malignancies in Patient-Derived Orthotopic Xenograft (PDOX) Murine Models.Cells. 2019  16;8.  pii: E599. doi: 10.3390/cells8060599. Review.

17.Murakami T, Matsuyama R, Ueda M, Mochizuki Y, Homma Y, Kameda K, Yazawa K, Izumisawa Y, Fukushima T, Kamimukai N, Yoshida K, Kamiya N, Hoffman RM, Endo I.High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater. World J Surg Oncol. 2019 Aug 9;17(1):140.

18.藤野真史、小杉千弘、首藤潔彦、森 幹人、成島一夫、細川 勇、高橋理彦、山崎将人、清水宏明、宮澤幸正、幸田圭史:特集 当直医必携「右下腹部痛」を極める 非腫瘍性病変の治療 虫垂炎の保存治療とinteval surgery 臨床外科74(1): 34-37 2019

19.清水宏明:医学の窓 各科の話題187 外科2胆道癌による閉塞性黄疸に対する術前胆道ドレナージ法について 千葉県医師会雑誌71(3): 111-112

20.清水 宏明:血管浸潤を伴う肝胆道癌の外科治療の現況(特集によせて)日外会誌.2019: 120;158.

21.清水宏明、細川 勇、山崎将人、藤野真史、幸田圭史.「胆道専門医講座」:胆道癌手術のために知っておくべき外科局所解剖. 胆道 2019, 33:48-53.

22.森 幹人:医学の窓 各科の話題187 外科3消化器手術におけるICG蛍光イメージシステムを用いた新たな試み 千葉県医師会雑誌71(3): 113

23.細川 勇、清水宏明、幸田圭史、宮崎 勝、大塚将之:特集 良性胆管狭窄に対する診療の実際 良性胆管空腸吻合部狭窄に対する外科治療胆と膵40(7):649-654 2019

24.細川勇、清水宏明肝門部領域胆管癌に対する外科切除の適応拡大と治癒切除率向上の取り組み 

日本医事新報 2019;33:28-33

25.江藤亮太郎, 野島広之, 鈴木大亮, 高橋誠, 吉富秀幸, 高屋敷吏, 大塚将之. 膵十二指腸動脈瘤破裂による血腫形成に起因する門脈血流不全に対しハイブリッド治療を行い救命し得た1例.日本腹部救急 2019: 39; 

26.藤井康矢, 野島広之, 酒井望、久保木知, 大塚将之 術中判断でALPPSに変更したVp3腫瘍栓を伴う進行肝細 胞癌の1例 千葉外科医雑誌 2019: 5; 37- 42 

▲このページのトップに戻る